Revascularization is often performed in patients with stable ischemic heart disease (SIHD). However, whether revascularization reduces death and other cardiovascular outcomes is uncertain. Cumulative evidence from this meta-analysis of randomized trials, including the recently published ISCHEMIA and ISCHEMIA-CKD trials, shows that routine revascularization was not associated with improved survival, but was associated with a lower risk of non-procedural MI and unstable angina with greater freedom from angina at the expense of higher rates of procedural MI. The risk benefits of routine revascularization versus initial medical therapy should be used in shared decision making for the management of patients with stable ischemic heart disease. Longer-term follow-up of trials is needed to assess whether reduction in non-fatal spontaneous events improves long-term survival.
Notes to editors
o A PCR Press Release on " Routine Revascularization vs. Medical therapy: Meta-analysis and Review " by Sripal Bangalore
o Presentation during the #PCR e-Course - http://www.
o Session on Main Arena Channel, Friday 26 June - 16:46 Paris time (UTC+2)
o PCR e-Course: 25, 26, 27 June 2020
The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. PCR offers a wide range of other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual Courses across the globe, e-Learning with high-profile PCR Webinars, Courses specifically dedicated to valvular heart disease, tailor-made PCR Seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.
Gateways to all PCR activities are available on http://www.
For further information, please contact Célia Vilà: email@example.com